Skip to main navigation Skip to search Skip to main content

Targeting the dynamic HSP90 complex in cancer

  • National Institutes of Health

Research output: Contribution to journalReview articlepeer-review

1357 Scopus citations

Abstract

The molecular chaperone heat shock protein 90 (HSP90) has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90. However, although recent reports of the early clinical efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiology.

Original languageEnglish
Pages (from-to)537-549
Number of pages13
JournalNature Reviews Cancer
Volume10
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Dive into the research topics of 'Targeting the dynamic HSP90 complex in cancer'. Together they form a unique fingerprint.

Cite this